The Sept. 3, 2015, joint meeting of the NCATS Advisory Council and the Cures Acceleration Network Review Board featured the following meeting materials.
Presentations
- NCATS Director’s Report (PDF - 2MB) – Christopher P. Austin, M.D., director, NCATS
- Developing the NIH-wide Strategic Plan (PDF - 2MB) - Lawrence A. Tabak, D.D.S., Ph.D., principal deputy director, NIH
- Development of an Integrated Ex Vivo Female Reproductive Tract: Drug Discovery and Testing for the Future (PDF - 5MB) - Teresa K. Woodruff, Ph.D., director, Women’s Health Research Institute; chief, Division of Obstetrics and Gynecology-Fertility Preservation; professor, Northwestern University
- Concept Clearance: Drug Repurposing/Repositioning (PDF - 131KB) - Christine M. Colvis, Ph.D., director, Drug Development Partnership Programs, NCATS
- Concept Clearance: Translational Research Informatics and Operations Support (PDF - 113KB) - Michelle A. Culp, B.S.N., M.P.H., director, Office of Clinical Trials Operations and Management, NCATS
- Concept Clearance: Bioethics Research in Biomedical and Translational Science (PDF - 107KB) - Elaine Collier, M.D., senior advisor, Office of the Director, NCATS
- NCATS Strategic Planning (PDF - 1MB) - Dorit Zuk, Ph.D., director, Office of Policy, Communications and Strategic Alliances, NCATS
- The CTSA Program: Collaborative Innovation for Translational Research (PDF - 1MB) - Petra Kaufmann, M.D., M.Sc., director, Division of Clinical Innovation and Office of Rare Diseases Research, NCATS
Additional Meeting Information
- Agenda (PDF - 135KB)
- Videocast
- Minutes (PDF - 180KB)
- Federal Register Notice
- Concept Clearances